We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A 90-year-old woman was referred by her ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Credit: Getty Images. Tepezza is a human insulin-like growth factor-1 receptor inhibitor. Tepezza ® (teprotumumab-trbw) significantly reduced proptosis in adults with chronic thyroid eye disease (TED) ...

Please provide your email address to receive an email when new articles are posted on . A 78-year-old woman was referred to the neuro-ophthalmology service at New England Eye Center for several months ...

Findings from THRIVE showed treatment with veligrotug led to statistically significant improvements in the signs and symptoms of TED. Topline data were announced from a phase 3 study evaluating ...